Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence.
CONCLUSION: The outcome of rSLNB is not an important prognostic factor for distant recurrence, and its value as a staging tool in patients with IBTR seems disputable.
PMID: 30908615 [PubMed - in process]
Source: The British Journal of Surgery - Category: Surgery Authors: Poodt IGM, Vugts G, Schipper RJ, Roumen RMH, Rutten HJT, Maaskant-Braat AJG, Voogd AC, Nieuwenhuijzen GAP, Sentinel Node and Recurrent Breast Cancer (SNARB) study group Tags: Br J Surg Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Statistics | Study | Surgery | UK Health